Evidence map›Paper›PMID 39464244›Full record

ArticleJournal of biomedical optics2024

Accuracy enhancement of metabolic index-based blood glucose estimation with a screening process for low-quality data.

Tomoya Nakazawa, Keiji Morishita, Anna Ienaka, Takeo Fujii, Masaki Ito, Fumie Matsushita

Abstract read
In one paragraph

Article in Journal of biomedical optics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tomoya NakazawaHamamatsu Photonics K.K., Electron Tube Division, Shimokanzo, Iwata, Japan.ORCID 0009-0008-8854-9781
Keiji MorishitaHamamatsu Photonics K.K., Electron Tube Division, Shimokanzo, Iwata, Japan.
Anna IenakaHamamatsu Photonics K.K., Intellectual Property Headquarters, Hamamatsu, Japan.
Takeo FujiiHamamatsu Photonics K.K., Electron Tube Division, Shimokanzo, Iwata, Japan.
Masaki ItoHamamatsu Photonics K.K., Electron Tube Division, Shimokanzo, Iwata, Japan.
Fumie MatsushitaHamamatsu Photonics K.K., Electron Tube Division, Shimokanzo, Iwata, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Significance: Many researchers have proposed various non-invasive glucose monitoring (NIGM) approaches using wearable or portable devices. However, due to the limited capacity of detectors for such compact devices and the movement of the body during measurement, the precision of the acquired data frequently diminishes, which can cause problems during actual use in daily life. In addition, intensive smoothing is often used in post-processing to mitigate the effects of erroneous values. However, this requires a considerable amount of data and results in a delay in the response to the actual blood glucose level (BGL). Aim: Instead of just applying data smoothing in the post-process of the data acquisition, we propose an active low-quality data screening method in the pre-process. In the proposal phase of the screening process, we employ an analytical approach to examine and formulate factors that might affect the BGL estimation accuracy. Approach: A signal quality index inspired by the standard deviation concept is introduced to detect visually apparent noise on signals. Furthermore, the total estimation error in the metabolic index (MI) is calculated based on potential perturbations defined by the signal-to-noise ratio (SNR) and the uncertainty due to discrete sampling. Thereafter, the acquired data were screened by these quality indices. Results: By applying the proposed data screening process to the data obtained from a commercially available smartwatch device in the pre-process, the estimation accuracy of the MI-based BGL was improved significantly. Conclusions: Adopting the proposed screen process improves BGL estimation accuracy in the smartwatch-based prototype. Applying the proposed screen process will facilitate the integration of wearable and continuous BGL monitoring into size- and SNR-limited devices such as smartwatches and smart rings.

Indexed as

Blood GlucoseBlood Glucose Self-MonitoringSignal Processing, Computer-AssistedSignal-To-Noise RatioAlgorithmsHumansWearable Electronic DevicesBlood Glucoseaccuracy improvementalgorithmnear-infrared spectroscopynon-invasive blood glucose measurement

Identifiers

PMID39464244
PMCPMC11503645

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.